Passage Bio (NYSE:GFL) – Equities research analysts at National Bank Financial raised their Q2 2020 earnings estimates for Passage Bio in a research report issued on Wednesday, June 24th. National Bank Financial analyst R. Merer now forecasts that the company will post earnings of ($0.14) per share for the quarter, up from their prior estimate of ($0.15). National Bank Financial currently has a “Outperform” rating on the stock. National Bank Financial also issued estimates for Passage Bio’s FY2021 earnings at ($0.41) EPS.
GFL has been the topic of a number of other reports. Stifel Nicolaus assumed coverage on Passage Bio in a research report on Monday, March 30th. They issued a “buy” rating and a $26.00 price target on the stock. Bank of America assumed coverage on Passage Bio in a research report on Monday, March 30th. They issued a “neutral” rating on the stock. Royal Bank of Canada boosted their price target on Passage Bio from $23.00 to $24.00 and gave the stock an “outperform” rating in a research report on Thursday, June 25th. Raymond James assumed coverage on Passage Bio in a research report on Monday, March 30th. They issued an “outperform” rating and a $18.00 price target on the stock. Finally, Barclays assumed coverage on Passage Bio in a research report on Monday, March 30th. They issued an “equal weight” rating and a $20.00 price target on the stock. Six research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $23.05.
Shares of GFL opened at $18.75 on Monday. The stock has a 50 day moving average of $18.37. Passage Bio has a 52 week low of $11.92 and a 52 week high of $20.97.
Passage Bio (NYSE:GFL) last posted its quarterly earnings data on Monday, May 11th. The company reported ($0.02) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.35) by $0.33. The firm had revenue of $694.42 million for the quarter, compared to the consensus estimate of $632.34 million.
About Passage Bio
GFL Environmental Inc operates as a diversified environmental services company in North America. The company offers non-hazardous solid waste management, infrastructure and soil remediation, and liquid waste management services. Its solid waste management business line includes the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste for municipal, residential, and commercial and industrial customers.
Recommended Story: What Are Cryptocurrencies?
Receive News & Ratings for Passage Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Passage Bio and related companies with MarketBeat.com's FREE daily email newsletter.